review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1086/315596 |
P8608 | Fatcat ID | release_p67gfylirzaetf2tj2pwjdn6aq |
P698 | PubMed publication ID | 10839724 |
P5875 | ResearchGate publication ID | 12478023 |
P2093 | author name string | Grayston JT | |
P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: design issues | Q33762181 | ||
The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae | Q33843538 | ||
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old) | Q34086738 | ||
ATYPICAL PNEUMONIA AND PSITTACOSIS. | Q35154848 | ||
Chlamydial infections of the heart | Q35660343 | ||
Chlamydia pneumoniae, strain TWAR pneumonia | Q36086894 | ||
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. | Q36240988 | ||
Chlamydia pneumoniae, strain TWAR, as the cause of an outbreak in a boys' school previously called psittacosis | Q36473368 | ||
Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline | Q37093492 | ||
Value of animal models for Chlamydia pneumoniae-related atherosclerosis | Q37877532 | ||
Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis | Q37877720 | ||
Azithromycin in control of trachoma | Q37877870 | ||
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice | Q37878302 | ||
Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study | Q37878753 | ||
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 | ||
Chlamydia infections and heart disease linked through antigenic mimicry | Q37878963 | ||
Antibiotics and risk of subsequent first-time acute myocardial infarction | Q37879181 | ||
Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients. | Q37879706 | ||
Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression | Q37880399 | ||
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse | Q37881023 | ||
Induction of macrophage foam cell formation by Chlamydia pneumoniae | Q37881436 | ||
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis | Q37881850 | ||
Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research | Q37881887 | ||
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen | Q37882581 | ||
Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent cough | Q37883379 | ||
Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae | Q37884222 | ||
Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone | Q37886683 | ||
An epidemic of infections due to Chlamydia pneumoniae in military conscripts | Q37890430 | ||
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries | Q37891287 | ||
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979 | Q37892533 | ||
Chlamydia pneumoniae infections in Norway 1981-87 earlier diagnosed as ornithosis | Q37895606 | ||
Culture-negative endocarditis probably due to Chlamydia pneumoniae | Q37897113 | ||
Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983. | Q37898201 | ||
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland | Q37900395 | ||
Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques | Q37901508 | ||
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections | Q37902805 | ||
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci | Q37904432 | ||
Myocarditis as a complication of infantile Chlamydia trachomatis pneumonitis | Q37906752 | ||
Pericardial and Myocardial Disease Associated with Serological Evidence of Infection by Agents of the Psittacosis-Lymphogranuloma Venereum Group (Chlamydiaceae) | Q37915028 | ||
Deoxyribonucleic Acid Relatedness of Chlamydia sp. Strain TWAR to Chlamydia trachomatis and Chlamydia psittaci | Q45311678 | ||
Chlamydia pneumoniae sp. nov. for Chlamydia sp. Strain TWAR | Q45311740 | ||
Infections and atherosclerosis: new clues from an old hypothesis? | Q53565811 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | atherosclerosis | Q12252367 |
Chlamydia pneumoniae | Q62869737 | ||
P304 | page(s) | S402-10 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Background and current knowledge of Chlamydia pneumoniae and atherosclerosis | |
P478 | volume | 181 Suppl 3 |